Clinical trial
Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome
NCT00208026 · Children's Hospital of Philadelphia, Other · Completed
Key facts
| NCT number | NCT00208026 |
|---|---|
| Title | Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome |
| Official title | Exploratory Safety and Systemic Absorption of Elidel (Pimecrolimus) 1% Cream for the Treatment of Netherton Syndrome |
| Lead sponsor | Children's Hospital of Philadelphia, Other |
| Collaborators | Novartis Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Netherton Syndrome |
| Intervention type | Drug |
| Interventions | Pimecrolimus 1% Cream |
| Enrollment | 3 |
| Start date | Sep 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Mar 1, 2008 |
| First posted | Sep 21, 2005 |
| Last update posted | Aug 14, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: